文献速递生殖医学

一项初步研究:利用培养液游离DNA二代测序检测的拷贝数变异对胚胎临床预测价值的研究

A pilot study to investigate the clinically predictive values of copy number variations detected by next-generation sequencing of cell-free deoxyribonucleic acid in spent culture media.
PubMed 文献 · Fertil Steril · 2024-02-19

该诊断/预后准确性研究纳入120例35岁及以下接受IVF-ICSI并择期单冻胚移植的患者,胚胎按常规形态学分级选择,对niPGT-A结果设盲,移植结局确定后分析培养液游离DNA的CNV。全染色体异常阳性预测值为94.4%(17/18),持续种植率5.6%(1/18),非存活相对风险RR 2.21(95%CI 1.66-2.94);其他CNV与无异常检出者的持续种植率相似。作者结论认为全染色体异常有高阳性预测值和显著RR,其他CNV结局相似,需进一步研究验证niPGT-A的临床适用性。

要点

  • 全染色体异常阳性预测值94.4%(17/18),持续种植率5.6%(1/18),非存活RR 2.21(95%CI 1.66-2.94)。
  • 无异常检出样本的阴性预测值为57.3%(43/75)。
  • 其他CNV与无异常检出者的持续种植率相似,无显著差异。

核心结论

  • 全染色体异常与高阳性预测值及非存活的显著相对风险相关。
  • 其他CNV胚胎的持续种植率与无异常检出者相似。
  • 作者认为需进一步研究验证niPGT-A的临床适用性。

研究设计与样本

  • 诊断/预后准确性研究,单中心私立IVF中心。
  • 纳入120例35岁及以下有IVF-ICSI指征并择期单冻胚移植的患者。
  • 胚胎按常规分级选择,对niPGT-A结果设盲,临床结局确定后分析培养液样本。
  • 对705枚剩余胚胎进行二次描述性分析。

主要发现

  • 120例完成研究;NGS判读:7.5%(n=9)质控失败,62.5%(n=75)未检出CNV,30%(n=36)检出异常拷贝数。
  • 异常NGS分层:15%(n=18)全染色体异常,15%(n=18)生殖潜能不确定;全染色体异常中27.8%(n=5)存在中间型CNV。
  • 无异常检出样本的阴性预测值为57.3%(43/75)。
  • 全染色体异常阳性预测值94.4%(17/18),持续种植率5.6%(1/18),非存活RR 2.21(95%CI 1.66-2.94),对照为无异常检出。
  • 其他CNV与无异常检出者在持续种植率或非存活RR上无显著差异;性染色体比例不等提示母源污染不罕见。

临床怎么用

  • 作者认为需进一步研究验证niPGT-A的临床适用性。

局限性

  • 作者指出需进一步研究验证niPGT-A的临床适用性。
  • 性染色体比例不等提示母源污染不罕见。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the positive predictive value and false positive risk of copy number variations (CNV's) detected in cell free deoxyribonucleic acid (DNA) from spent culture media for nonviable or aneuploid embryos. DESIGN: Diagnostic/prognostic accuracy study. PATIENT(S): Patients aged 35 and younger with an indication for IVF-ICSI and elective single frozen embryo transfer at a single, private IVF center. INTERVENTION: Embryo selection was performed according to the conventional grading, blinded to noninvasive preimplantation genetic testing for aneuploidy (niPGT-A) results. After clinical outcomes were established, spent culture media samples were analyzed. MAIN OUTCOME MEASURES: Prognostic accuracy of CNVs according to niPGT-A results to predict nonviability or clinical aneuploidy. RESULTS: One hundred twenty patients completed the study. Interpretations of next-generation sequencing (NGS) profiles were as follows: 7.5% (n = 9) failed quality control; 62.5% (n = 75) no CNVs detected; and 30% (n = 36) abnormal copy number detected. Stratification of abnormal NGS profiles was as follows: 15% (n = 18) whole chromosome and 15% (n = 18) uncertain reproductive potential. An intermediate CNV was evident in 27.8% (n = 5) of the whole chromosome abnormalities. The negative predictive value for samples with no detected abnormality was 57.3% (43/75). Whole chromosome abnormality was associated with a positive predictive value of 94.4% (17/18), lower sustained implantation rate (5.6%, 1/18), and higher relative risk (RR) for nonviability compared with no detected abnormalities (RR 2.21, 95% CI: 1.66-2.94). No other CNVs were associated with significant differences in the sustained implantation or RRs for nonviability. Unequal sex chromosome proportions suggested that maternal contamination was not uncommon. A secondary descriptive analysis of 705 supernumerary embryos revealed proportions of NGS profile interpretations similar to the transferred cohort. Significant median absolute pairwise differences between certain subcategories of CNV abnormalities were apparent. CONCLUSION: Whole chromosome abnormalities were associated with a high positive predictive value and significant RR for nonviability. Embryos associated with other CNVs had sustained implantation rates similar to those with no abnormalities detected. Further studies are required to validate the clinical applicability of niPGT-A. CLINICAL TRIAL REGISTRATION NUMBER: clinicaltrials.gov (NCT04732013).

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Nakhuda G, Rodriguez S, Tormasi S, et al. A pilot study to investigate the clinically predictive values of copy number variations detected by next-generation sequencing of cell-free deoxyribonucleic acid in spent culture media. Fertil Steril. 2024. PMID: 38382698. doi:10.1016/j.fertnstert.2024.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。